Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 503260

Targeting Fas in osteoresorptive disorders


Kovačić, Nataša; Grčević, Danka; Katavić, Vedran; Lukić, Ivan krešimir; Marušić, Ana
Targeting Fas in osteoresorptive disorders // Expert opinion on therapeutic targets, 14 (2010), 10; 1121-1134 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 503260 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Targeting Fas in osteoresorptive disorders

Autori
Kovačić, Nataša ; Grčević, Danka ; Katavić, Vedran ; Lukić, Ivan krešimir ; Marušić, Ana

Izvornik
Expert opinion on therapeutic targets (1472-8222) 14 (2010), 10; 1121-1134

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Fas; Fas ligand; bone

Sažetak
IMPORTANCE OF THE FIELD: Fas receptor is a mediator of the external apoptotic pathway in many cells and tissues. It is proposed that Fas receptor mediates osteoresorptive effects of estrogen deficiency and local/systemic inflammation. AREAS COVERED IN THIS REVIEW: This review covers the past two decades of research on the expression and function of the Fas-Fas ligand system on bone cells, involvement in the pathogenesis of osteoresorption and potential therapeutic modulation. WHAT THE READER WILL GAIN: We review the structure, biological function and intracellular signaling pathways of the Fas-Fas ligand system emphasizing the role of the non-apoptotic signaling pathways in bone cells, particularly osteoblast differentiation. We also present data on the in vitro expression and function of the Fas-Fas ligand system on osteoblast/osteoclast lineage cells, animal and human studies confirming its involvement in osteoresorptive disorders and potential therapeutic approaches to modulate its function. TAKE HOME MESSAGE: Tissue specific therapeutic approaches need to be established to modify the Fas-Fas ligand system in osteoresorptive disorders as systemic targeting has many side effects. The most promising approach would be to target Fas signaling molecules coupled with osteoblast/osteoclast differentiation pathways, but a precise definition of these targets is still needed.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
108-1080229-0142 - Molekularni mehanizmi učinaka imunosnih poremećaja na kost (Grčević, Danka, MZOS ) ( CroRIS)
108-1080229-0341 - B limfociti, makrofagi i podrijetlo osteoklasta (Katavić, Vedran, MZOS ) ( CroRIS)
108-1080229-0140 - Molekularne interakcije koštanog i imunološkog sustava (Marušić, Ana, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Kovačić, Nataša; Grčević, Danka; Katavić, Vedran; Lukić, Ivan krešimir; Marušić, Ana
Targeting Fas in osteoresorptive disorders // Expert opinion on therapeutic targets, 14 (2010), 10; 1121-1134 (međunarodna recenzija, pregledni rad, znanstveni)
Kovačić, N., Grčević, D., Katavić, V., Lukić, I. & Marušić, A. (2010) Targeting Fas in osteoresorptive disorders. Expert opinion on therapeutic targets, 14 (10), 1121-1134.
@article{article, author = {Kova\v{c}i\'{c}, Nata\v{s}a and Gr\v{c}evi\'{c}, Danka and Katavi\'{c}, Vedran and Luki\'{c}, Ivan kre\v{s}imir and Maru\v{s}i\'{c}, Ana}, year = {2010}, pages = {1121-1134}, keywords = {Fas, Fas ligand, bone}, journal = {Expert opinion on therapeutic targets}, volume = {14}, number = {10}, issn = {1472-8222}, title = {Targeting Fas in osteoresorptive disorders}, keyword = {Fas, Fas ligand, bone} }
@article{article, author = {Kova\v{c}i\'{c}, Nata\v{s}a and Gr\v{c}evi\'{c}, Danka and Katavi\'{c}, Vedran and Luki\'{c}, Ivan kre\v{s}imir and Maru\v{s}i\'{c}, Ana}, year = {2010}, pages = {1121-1134}, keywords = {Fas, Fas ligand, bone}, journal = {Expert opinion on therapeutic targets}, volume = {14}, number = {10}, issn = {1472-8222}, title = {Targeting Fas in osteoresorptive disorders}, keyword = {Fas, Fas ligand, bone} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font